(2026). An immunogenic cell death-based signature predicts prognosis and immune landscape in triple-negative breast cancer. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"An Immunogenic Cell Death-based Signature Predicts Prognosis and Immune Landscape in Triple-negative Breast Cancer."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"An Immunogenic Cell Death-based Signature Predicts Prognosis and Immune Landscape in Triple-negative Breast Cancer."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.